1. Home
  2. ATYR vs OFS Comparison

ATYR vs OFS Comparison

Compare ATYR & OFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

N/A

Current Price

$0.54

Market Cap

46.1M

Sector

Health Care

ML Signal

N/A

Logo OFS Capital Corporation

OFS

OFS Capital Corporation

N/A

Current Price

$3.34

Market Cap

54.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ATYR
OFS
Founded
2005
2001
Country
United States
United States
Employees
58
47
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
46.1M
54.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATYR
OFS
Price
$0.54
$3.34
Analyst Decision
Hold
Analyst Count
9
0
Target Price
$3.67
N/A
AVG Volume (30 Days)
2.0M
80.8K
Earning Date
05-01-2026
04-30-2026
Dividend Yield
N/A
16.83%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$17.44
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$2.72
52 Week High
$7.29
$8.99

Technical Indicators

Market Signals
Indicator
ATYR
OFS
Relative Strength Index (RSI) 50.61 42.47
Support Level $0.42 $3.31
Resistance Level $0.59 $4.40
Average True Range (ATR) 0.04 0.17
MACD 0.02 -0.02
Stochastic Oscillator 75.87 11.24

Price Performance

Historical Comparison
ATYR
OFS

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

About OFS OFS Capital Corporation

OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to provide its stockholders with both current income and capital appreciation through debt investments and, to a lesser extent, equity investments.

Share on Social Networks: